Shujun Wan

573 total citations
17 papers, 417 citations indexed

About

Shujun Wan is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Shujun Wan has authored 17 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Physiology. Recurrent topics in Shujun Wan's work include RNA modifications and cancer (5 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Shujun Wan is often cited by papers focused on RNA modifications and cancer (5 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Shujun Wan collaborates with scholars based in China, Germany and Taiwan. Shujun Wan's co-authors include Jia Wu, Jiaxi Song, Cheng Wang, Chen‐Yu Zhang, Junjun Wang, Yujie Xing, Qiang Hua, Simin Zhou, Xiang-jian Meng and Dongmei Niu and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Journal of Neurochemistry.

In The Last Decade

Shujun Wan

16 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shujun Wan China	10	231	162	65	55	47	17	417
Zhibo Chen China	14	168 0.7×	105 0.6×	70 1.1×	33 0.6×	18 0.4×	37	427
Yu‐Qing Ni China	11	373 1.6×	243 1.5×	54 0.8×	51 0.9×	31 0.7×	19	547
Lei Mi China	11	166 0.7×	64 0.4×	44 0.7×	64 1.2×	14 0.3×	33	395
Shiqiong Huang China	9	323 1.4×	203 1.3×	36 0.6×	67 1.2×	134 2.9×	19	551
Yanxian Lai China	13	224 1.0×	140 0.9×	46 0.7×	107 1.9×	47 1.0×	35	679
Jiangtao Yan China	12	159 0.7×	64 0.4×	62 1.0×	66 1.2×	80 1.7×	23	460
Liangping Zhao China	12	180 0.8×	142 0.9×	47 0.7×	61 1.1×	32 0.7×	26	434
Yunye Ning China	18	301 1.3×	168 1.0×	38 0.6×	74 1.3×	16 0.3×	29	608
Hai Zhou China	15	335 1.5×	245 1.5×	32 0.5×	164 3.0×	26 0.6×	48	710

Countries citing papers authored by Shujun Wan

Since Specialization

Citations

This map shows the geographic impact of Shujun Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujun Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujun Wan more than expected).

Fields of papers citing papers by Shujun Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujun Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujun Wan. The network helps show where Shujun Wan may publish in the future.

Co-authorship network of co-authors of Shujun Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Shujun Wan. A scholar is included among the top collaborators of Shujun Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujun Wan. Shujun Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhang, Yan, Zhi-yuan Chen, Kai Li, et al.. (2025). β-Hydroxybutyrate ameliorates lipopolysaccharide-induced liver injury through β-hydroxybutyrylation of the SOD2 protein in mice. Redox Biology. 88. 103949–103949.

Xing, Yujie, Tao Ma, Kai Li, et al.. (2024). β-Hydroxybutyrate suppresses M1 macrophage polarization through β-hydroxybutyrylation of the STAT1 protein. Cell Death and Disease. 15(12). 874–874. 13 indexed citations

Li, Lei, Jing Li, Min Zhong, et al.. (2024). Nanozyme-enhanced tyramine signal amplification probe for preamplification-free myocarditis-related miRNAs detection. Chemical Engineering Journal. 503. 158093–158093. 28 indexed citations

Kong, Xiang, Shujun Wan, Lan Jiang, et al.. (2024). Increased serum extrachromosomal circular DNA SORBS1circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus. Cellular & Molecular Biology Letters. 29(1). 12–12. 11 indexed citations

Zhou, Simin, Yi Cheng, Yujie Xing, et al.. (2024). Metformin enhances METTL14-Mediated m6A methylation to alleviate NIT-1 cells apoptosis induced by hydrogen peroxide. Heliyon. 10(2). e24432–e24432. 5 indexed citations

Wan, Shujun. (2023). Argumentationsstrategien chinesischer Deutschlerner/-innen. OAPEN (The OAPEN Foundation). 1 indexed citations

Xing, Yujie, Teng Zhang, Shujun Wan, et al.. (2023). LncRNA HEM2ATM improves obesity-associated adipose tissues meta-inflammation and insulin resistance by interacting with heterogeneous nuclear ribonucleoprotein U. Clinical Immunology. 247. 109234–109234. 9 indexed citations

Zhou, Simin, Yue Sun, Yujie Xing, et al.. (2022). Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m6A methylation. European Journal of Pharmacology. 924. 174960–174960. 22 indexed citations

Wan, Shujun, Qiang Hua, Yujie Xing, et al.. (2022). Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus. Frontiers in Endocrinology. 13. 986419–986419. 8 indexed citations

10.

Cheng, Yi, Simin Zhou, Yue Sun, et al.. (2022). The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression. Frontiers in Endocrinology. 13. 910868–910868. 21 indexed citations

11.

Xing, Yujie, Shujun Wan, Yi Cheng, et al.. (2021). A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro. Frontiers in Pharmacology. 12. 708177–708177. 56 indexed citations

12.

Wan, Shujun, et al.. (2019). . 88–96. 4 indexed citations

13.

Ye, Lei, et al.. (2017). Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease. Medicine. 96(11). e6323–e6323. 18 indexed citations

14.

Wan, Shujun, Jun Wang, Jia Wu, et al.. (2017). Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications. Diabetes Research and Clinical Practice. 130. 171–179. 53 indexed citations

15.

Wang, Cheng, Shujun Wan, Dongmei Niu, et al.. (2016). Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Scientific Reports. 6(1). 20032–20032. 93 indexed citations

16.

Song, Jiaxi, Cheng Wang, Jia Wu, et al.. (2016). Elevated serum miR‐93, miR‐191, and miR‐499 are noninvasive biomarkers for the presence and progression of traumatic brain injury. Journal of Neurochemistry. 137(1). 122–129. 74 indexed citations

17.

Ma, Weimin & Shujun Wan. (2010). Competitive Analysis on Financial Leasing Problem. 25. 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact